← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Albert Einstein College Of Medicine, Inc.
Bronx
$9,397,581
Total funding
19
Grants
Funding over time
peak $2.9M · FY2012–19$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
DOD$7,416,452 · 14
NSF$1,981,129 · 5
By mechanism
—$9,397,581 · 19
Investigators at Albert Einstein College Of Medicine, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
CANNABIDIVARIN (CBDV) VERSUS PLACEBO IN CHILDREN WITH AUTISM SPECTRUM DISORDER (ASD)$1,267,800
· FY2017 · Defense Health Agency
TARGETING THE EPIGENETIC REGULATOR MLL3 MUTATIONS IN BREAST CANCER$1,252,500
· FY2016 · Department of the Army
PI3K SIGNALING IN TUMOR CELLS AND STROMA REGULATES BREAST CANCER METASTASIS$1,252,500
· FY2019 · Department of the Army
The oscillatory control of selective attention: leveraging white matter microstructure and electrophysiology$758,865
· FY2012 · SBE
VULNERABILITIES, RISKS AND INTERPLAY OF POSTTRAUMATIC DEPRESSION AND EPILEPSY: ROLE OF MONOAMINERGIC CIRCUITS$684,297
· FY2018 · Department of the Army
INHIBITION OF MICROBIAL BETA-GLUCURONIDASE AS A STRATEGY TOWARD BREAST CANCER CHEMOPREVENTION$626,236
· FY2017 · Department of the Army
EXPLORING ANTITUMOR IMMUNE RESPONSE IN A NOVEL MLL3-MUTANT BREAST CANCER MODEL$500,871
· FY2017 · Department of the Army
EXPLORING ANTITUMOR IMMUNE RESPONSE IN A NOVEL MLL3-MUTANT BREAST CANCER MODEL$500,238
· FY2017 · Department of the Army
Reactive Intermediates in cytochrome oxidase$439,997
· FY2014 · MPS
Mechanistic Studies of Ribonucleotide Reductase$403,527
· FY2012 · MPS
Collaborative Research: How can bacterial viruses succeed in the marine environment?$348,490
· FY2014 · GEO
FURTHER DEVELOPMENT OF AN EXHALED MICRORNA BIOMARKER OF LUNG CANCER RISK$331,355
· FY2016 · Department of the Army
MECHANISMS OF TRANSENDOTHELIAL MIGRATION OF PRIMARY HUMAN INVASIVE DUCTAL CARCINOMA CELLS FROM ER+, HER2+, AND TRIPLE-NEGATIVE DISEASE$329,210
· FY2014 · Department of the Army
MICROENVIRONMENTS AND SIGNALING PATHWAYS REGULATING EARLY DISSEMINATION, DORMANCY, AND METASTASIS$292,251
· FY2014 · Department of the Army
THE ROLE OF MISMATCH REPAIR AND MICROBIOME IN INFLAMMATION-ASSOCIATED COLON CANCER$243,920
· FY2016 · Department of the Army
THE ROLE SKP2 IN THE PROSTATE TUMORIGENESIS FOLLOWING RB AND P53 LOSS$120,273
· FY2013 · Department of the Army
International Congress of Neuroethology, Montevideo, Uruguay, March 30 - April 3, 2016$30,250
· FY2016 · BIO
TAS::57 3600::TAS "12TH INTERNATIONAL CONGRESS OF NEUROLOGY (ICN)"$15,000
· FY2016 · Department of Defense
FILIP1L INHIBITS OVARIAN CANCER METASTASIS THROUGH INHIBITION OF WNT SIGNALING$0
· FY2015 · Department of the Army